In the Media (DUPLICATE)

Zero Candida Technologies August 7th OTCQB Venture Virtual Investor Conference Presentation

Zero Candida begins trading on OTCQB, advances AI-driven women’s health solutions

Zero Candida secures patent in South Africa for revolutionary AI-powered fungal treatment device

Zero Candida celebrates TSX Venture listing and debuts treatment for recurrent yeast infections

Zero Candida Technologies Inc. (TSXV: ZCT) Opens the Market Monday, November 25 2024

Zero Candida, an Israeli FemTech medical device start-up applying to list on TSX Venture Exchange